Brain, Vol. 123, No. 8, 1703-1709,
August 2000
© 2000 Oxford University Press
The development of cutaneous allodynia during a migraine attack Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine
.
1 Departments of Anesthesia and Critical Care, and 2 Neurology, Beth Israel Deaconess Medical Center, 3 Department of Neurology, Massachusetts General Hospital, and 4 Department of Neurobiology and the 5 Program in Neuroscience, Harvard Medical School, Boston, Massachusetts, USA
Correspondence to:
Rami Burstein, Department of Anesthesia and Critical Care, Harvard Institutes of Medicine, Room 830, 77 Avenue Louis Pasteur, Boston, MA 02115, USA E-mail: rburstei{at}caregroup.harvard.edu
Recently, we showed that most migraine patients exhibit cutaneous allodynia inside and outside their pain-referred areas when examined during a fully developed migraine attack. In this report, we studied the way in which cutaneous allodynia develops by measuring the pain thresholds in the head and forearms bilaterally at several time points during a migraine attack in a 42-year-old male. Prior to the headache, he experienced visual, sensory, motor and speech aura. During the headache, he experienced photo-, phono- and odour-phobia, nausea and vomiting, worsening of the headache by coughing or moving his head, and cutaneous pain when shaving, combing his hair or touching his scalp. Comparisons between his pain thresholds in the absence of migraine and at 1, 2 and 4 h after the onset of migraine revealed the following. (i) After 1 h, mechanical and cold allodynia started to develop in the ipsilateral head but not in any other site. (ii) After 2 h, this allodynia increased on the ipsilateral head and spread to the contralateral head and ipsilateral forearm. (iii) After 4 h, heat allodynia was also detected while mechanical and cold allodynia continued to increase. These clinical observations suggest the following sequence of events along the trigeminovascular pain pathway of this patient. (i) A few minutes after the initial activation of his peripheral nociceptors, they became sensitized; this sensitization can mediate the symptoms of intracranial hypersensitivity. (ii) The barrage of impulses that came from the peripheral nociceptors activated second-order neurons and initiated their sensitization; this sensitization can mediate the development of cutaneous allodynia on the ipsilateral head. (iii) The barrage of impulses that came from the sensitized second-order neurons activated and eventually sensitized third-order neurons; this sensitization can mediate the development of cutaneous allodynia on the contralateral head and ipsilateral forearm at the 2-h point, over 1 h after the appearance of allodynia on the ipsilateral head. This interpretation calls for an early use of anti-migraine drugs that target peripheral nociceptors, before the development of central sensitization. If central sensitization develops, the therapeutic rationale is to suppress it. Because currently available drugs that aim to suppress central sensitization are ineffective, this study stresses the need to develop them for the treatment of migraine.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. R Charbit, S. Akerman, and P. J Goadsby Comparison of the Effects of Central and Peripheral Dopamine Receptor Activation on Evoked Firing in the Trigeminocervical Complex J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 752 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Charbit, S. Akerman, P. R. Holland, and P. J. Goadsby Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study J. Neurosci., October 7, 2009; 29(40): 12532 - 12541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Cady The Future of Migraine: Beyond Just Another Pill Mayo Clin. Proc., May 1, 2009; 84(5): 397 - 399. [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Bigal and R. B. Lipton Clinical course in migraine: Conceptualizing migraine transformation Neurology, September 9, 2008; 71(11): 848 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Bigal, S. Ashina, R. Burstein, M. L. Reed, D. Buse, D. Serrano, R. B. Lipton, and On behalf of the AMPP Group Prevalence and characteristics of allodynia in headache sufferers: A population study Neurology, April 22, 2008; 70(17): 1525 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Brandes, D. Kudrow, S. R. Stark, C. P. O'Carroll, J. U. Adelman, F. J. O'Donnell, W. J. Alexander, S. E. Spruill, P. S. Barrett, and S. E. Lener Sumatriptan-Naproxen for Acute Treatment of Migraine: A Randomized Trial JAMA, April 4, 2007; 297(13): 1443 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mitrirattanakul and R. L. Merrill Headache impact in patients with orofacial pain. J Am Dent Assoc, September 1, 2006; 137(9): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Ahn and A. I. Basbaum Tissue Injury Regulates Serotonin 1D Receptor Expression: Implications for the Control of Migraine and Inflammatory Pain. J. Neurosci., August 9, 2006; 26(32): 8332 - 8338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jakubowski, S. Silberstein, A. Ashkenazi, and R. Burstein Can allodynic migraine patients be identified interictally using a questionnaire? Neurology, November 8, 2005; 65(9): 1419 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Ramadan Targeting therapy for migraine: What to treat? Neurology, May 24, 2005; 64(10_suppl_2): S4 - S8. [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Afridi, M. S. Matharu, L. Lee, H. Kaube, K. J. Friston, R. S. J. Frackowiak, and P. J. Goadsby A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate Brain, April 1, 2005; 128(4): 932 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Hershey and P. K. Winner Pediatric Migraine: Recognition and Treatment J Am Osteopath Assoc, April 1, 2005; 105(4_suppl): 2S - 8S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Woolf Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management Ann Intern Med, March 16, 2004; 140(6): 441 - 451. [Full Text] [PDF]
|
|
|
|
|
|
R. B. Lipton and J. Pan Is Migraine a Progressive Brain Disease? JAMA, January 28, 2004; 291(4): 493 - 494. [Full Text] [PDF]
|
|
|
|
|
|
P. Winner, L. K. Mannix, D. G. Putnam, S. McNeal, J. Kwong, S. O'Quinn, and M. S. Richardson Pain-Free Results With Sumatriptan Taken at the First Sign of Migraine Pain: 2 Randomized, Double-Blind, Placebo-Controlled Studies Mayo Clin. Proc., October 1, 2003; 78(10): 1214 - 1222. [Abstract] [PDF]
|
|
|
|
|
|
T. Bartsch and P. J. Goadsby Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater Brain, August 1, 2003; 126(8): 1801 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Drummond and A. Granston Facilitation of extracranial vasodilatation to limb pain in migraine sufferers Neurology, July 8, 2003; 61(1): 60 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.B. Lipton, S.D. Silberstein, J.R. Saper, M.E. Bigal, and P.J. Goadsby Why headache treatment fails Neurology, April 8, 2003; 60(7): 1064 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Lake III and J. R. Saper Chronic headache: New advances in treatment strategies Neurology, September 10, 2002; 59(90052): S8 - 13. [Abstract] [Full Text]
|
|
|
|
|
|
T. Bartsch and P. J. Goadsby Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input Brain, July 1, 2002; 125(7): 1496 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.B. Lipton, R.K. Cady, W.F. Stewart, K. Wilks, and C. Hall Diagnostic lessons from the Spectrum Study Neurology, May 14, 2002; 58(90096): S27 - 31. [Abstract] [Full Text]
|
|